Literature DB >> 3741358

Thin myofilament proteins in norm and heart failure. I. Polymerizability of myocardial Straub actin in acute and chronic heart failure.

N V Karsanov, M P Pirtskhalaishvili, V J Semerikova, N Sh Losaberidze.   

Abstract

The reduced and intrinsic viscosities of myocardial Straub F-actin from the left ventricle of a practically healthy man were equal to 3.05 +/- 0.2 and 2.4 +/- 0.32 and from the right ventricle were 2.37 +/- 0.2 and 2.1 +/- 0.3 dl/g, respectively (the difference between ventricles was not significant). The average length of filaments measured by flow birefringence technique was equal to 1.3 +/- 0.04 micron, the number-average length (Ln), determined by the electron microscopy was 1.4 micron, the weight-average length (Lw), was 2 microns and the maximal one was 5.5 microns. The histograms showed that the most characteristic length was that of 0.8-1.2 micron. According to the flow birefringence data canine myocardial F-actin had a length similar to that of myocardial F-actin from a practically healthy man, though its reduced and intrinsic viscosities were higher. In acute and especially chronic congestive heart failure the actin polymerizability was sharply reduced. In consequence, in acute heart failure the number-average length of F-actin filaments was decreased by 43% and in congestive heart failure by 65.7%. The characteristic length in acute heart failure shifts to the range of 0.2-0.6 micron, while in congestive heart failure the range is 0.2-0.4 micron. This fact can possibly explain why during preparation of actin from the pathologically changed myocardium according to the methods including purification by the cycles of polymerization-sedimentation-depolymerization, the pathologically changed actin is discarded and the normal actin remains. A definite parallel was observed between the reduction of actin polymerizability and the ability of myocardial glycerinated fiber bundles (MBGF) to generate force. We conclude that the changes of actin properties in heart failure may cause a decrease in contractibility of the myocardial contractile protein system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741358     DOI: 10.1007/bf01907384

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  30 in total

1.  Electron microscopic study of alpha-actinin.

Authors:  Z A Podlubnaya; L A Tskhovrebova; M M Zaalishtsbvili; G A Stefanenko
Journal:  J Mol Biol       Date:  1975-02-25       Impact factor: 5.469

2.  A FLOW BIREFRINGENCE STUDY OF F-ACTIN.

Authors:  K MARUYAMA
Journal:  J Biochem       Date:  1964-03       Impact factor: 3.387

3.  Myofibrillar adenosine triphosphatase activity in congestive heart failure.

Authors:  N R ALPERT; M S GORDON
Journal:  Am J Physiol       Date:  1962-05

4.  Correlation between cardiac muscle myosin ATPase activity and velocity of muscle shortening.

Authors:  R A Carey; A A Bove; R L Coulson; J F Spann
Journal:  Biochem Med       Date:  1979-06

5.  Gamma-Actinin, a new regulatory protein from rabbit skeletal muscle. I. Purification and characterization.

Authors:  M Kuroda; K Maruyama
Journal:  J Biochem       Date:  1976-08       Impact factor: 3.387

6.  Comparison of turnover of several myofibrillar proteins and critical evaluation of double isotope method.

Authors:  R Zak; A F Martin; G Prior; M Rabinowitz
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

7.  Structural and functional changes of the contractile proteins in experimentally-induced cardiac hypertrophy in animals, and heart failure in man.

Authors:  S Oganessyan; T Zaminian; N Bay; V Petrosian; A Koschkarian; I Martirosian; M Eloyan
Journal:  J Mol Cell Cardiol       Date:  1973-02       Impact factor: 5.000

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Mechanism of physiologic versus pathologic ventricular hypertrophy process: enhanced or depressed myosin ATPase activity and contractility governed by type, degree and duration of inciting stress.

Authors:  J Wikman-Coffelt; M M Laks; T H Riemenschneider; D T Mason
Journal:  Basic Res Cardiol       Date:  1980 Jan-Feb       Impact factor: 17.165

10.  [Structural-functional alterations in contractile proteins in athyreotic dystrophy of the myocardium].

Authors:  N V Karsanov; D D Eristavi
Journal:  Biofizika       Date:  1983 Sep-Oct
View more
  1 in total

1.  In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.

Authors:  Guillem Jorba; Joaquim Aguirre-Plans; Valentin Junet; Cristina Segú-Vergés; José Luis Ruiz; Albert Pujol; Narcís Fernández-Fuentes; José Manuel Mas; Baldo Oliva
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.